V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290007138 | 290005460 | null | 55.5 | Palliative (P) | null | 2014-11-16 | Oxaliplatin + Raltitrexed | N | N | 290022307 | SUNITINIB |
| 290007139 | 290007314 | 1.69 | 90.3 | Neo-adjuvant (N) | 2017-01-21 | 2017-01-23 | LANREOTIDE | N | N | 290022311 | FLUOROURACIL + MITOMYCIN |
| 290007140 | 290005463 | 1.76 | 73.8 | Adjuvant (A) | 2017-11-03 | 2017-11-18 | Capecitabine | 02 | N | 290022312 | GEMCITABINE |
| 290007141 | 290005464 | null | 39.1 | Palliative (P) | 2013-07-28 | 2013-08-02 | Cisplatin 100 + RT(H&N) 1 day | 99 | N | 290022313 | CAPECITABINE |
| 290007142 | 290007315 | 1.62 | 65.8 | Adjuvant (A) | 2017-07-01 | 2017-07-01 | CARBOPLATIN + RT | 02 | N | 290022318 | CAPECITABINE + OXALIPLATIN |
| 290007143 | 290005465 | 1.73 | 60.2 | null | 2017-11-15 | 2018-03-26 | Rituximab | 02 | N | 290022326 | CETUXIMAB |
| 290007144 | 290005467 | 1.43 | null | Palliative (P) | null | 2015-02-06 | NIVOLUMAB | null | null | 290022333 | CAPECITABINE + CISPLATIN |
| 290007145 | 290005468 | null | 59 | Neo-adjuvant (N) | 2013-11-28 | 2013-11-30 | DABRAFENIB + TRAMETINIB | 02 | N | 290022338 | CAPECITABINE + OXALIPLATIN |
| 290007146 | 290005468 | 1.56 | 88 | Palliative (P) | 2018-08-06 | 2018-08-08 | CAPECITABINE + CARBOPLATIN | N | N | 290022338 | SUNITINIB |
| 290007147 | 290008039 | null | 52.6 | Curative (C) | 2018-02-01 | 2018-02-15 | Cisplatin 7 day | 02 | N | 290022347 | CARBOPLATIN + ETOPOSIDE |
| 290007148 | 290005469 | 1.6 | 60.3 | Disease modification (D) | 2013-03-25 | 2013-09-13 | Cisplatin + Radiotherapy | N | N | 290022349 | FLUOROURACIL + MITOMYCIN |
| 290007149 | 290007317 | 1.6 | null | Curative (C) | 2016-09-24 | 2016-10-22 | INTERAACT trial | 2 | N | 290022358 | RALTITREXED |
| 290007150 | 290007317 | null | 60.9 | null | 2015-07-05 | 2015-07-12 | LANREOTIDE | N | N | 290022358 | FLUOROURACIL + MITOMYCIN |
| 290007151 | 290005472 | 1.69 | 52 | Palliative (P) | 2016-02-04 | 2016-02-08 | Cisplatin | Y | N | 290022373 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 290007152 | 290005472 | 1.87 | 80.9 | Palliative (P) | 2014-12-10 | 2014-12-22 | Cisplatin + Etoposide (3 day) | 2 | N | 290022373 | DOXORUBICIN + OLARATUMAB |
| 290007153 | 290005475 | null | 71.7 | Disease modification (D) | 2013-09-22 | 2013-10-31 | Capecitabine (21days) + Carboplatin | N | N | 290022390 | OXALIPLATIN + RALTITREXED |
| 290007154 | 290005475 | 1.51 | 94 | Palliative (P) | 2015-10-15 | 2015-10-15 | Paclitaxel 7 day | 2 | N | 290022390 | TRIAL |
| 290007155 | 290005475 | null | 58.4 | Adjuvant (A) | 2018-01-02 | 2018-01-05 | null | null | null | 290022390 | CAPECITABINE + OXALIPLATIN |
| 290007156 | 290005477 | 0 | 91 | Curative (C) | 2013-03-17 | 2013-04-07 | LANREOTIDE | Y | N | 290022405 | CETUXIMAB |
| 290007157 | 290005478 | 1.75 | 69.5 | Adjuvant (A) | 2016-10-02 | 2016-10-17 | Capecitabine | N | N | 290022406 | MELPHALAN |
| 290007158 | 290005480 | 1.6 | 104.7 | Palliative (P) | 2014-08-18 | 2014-09-11 | Capecitabine (21 day) + Irinotecan | N | N | 290022408 | INTERAACT TRIAL |
| 290007159 | 290005482 | 1.8 | 51 | Palliative (P) | 2015-06-13 | 2015-06-18 | MCX | N | N | 290022413 | CAPECITABINE + CISPLATIN |
| 290007160 | 290005482 | 1.73 | 84.3 | Curative (C) | 2017-05-14 | 2017-06-15 | LANREOTIDE | N | Y | 290022413 | PACLITAXEL |
| 290007161 | 290005483 | null | 53.2 | Curative (C) | 2015-04-24 | 2015-05-20 | Capecitabine | N | N | 290022416 | MITOMYCIN |
| 290007162 | 290005484 | null | null | Curative (C) | 2015-07-31 | 2015-08-11 | CARBOPLATIN | N | N | 290022417 | CAPECITABINE + RT |
| 290007163 | 290005485 | 1.75 | null | Palliative (P) | 2017-06-15 | 2017-06-29 | CETUXIMAB | 02 | null | 290022420 | CAPECITABINE + OXALIPLATIN |
| 290007164 | 290005489 | 1.63 | 62 | null | 2015-12-02 | 2015-12-23 | Capecitabine + Cisplatin + RT | N | N | 290022421 | LANREOTIDE |
| 290007165 | 290005489 | 1.82 | 90.25 | null | null | 2017-08-17 | PACLITAXEL + TRASTUZUMAB | N | null | 290022421 | CAPECITABINE |
| 290007166 | 290005490 | 1.77 | 0 | Palliative (P) | 2017-05-05 | 2017-05-30 | LANREOTIDE | N | N | 290022433 | PACLITAXEL |
| 290007167 | 290005493 | 1.72 | 72.4 | Curative (C) | 2015-06-10 | 2015-06-24 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 290022437 | INTERAACT TRIAL |
| 290007168 | 290005494 | 1.69 | 68.4 | null | 2018-06-11 | 2018-07-05 | Y-90 | null | null | 290022438 | CETUXIMAB + RT |
| 290007169 | 290005496 | 1.67 | null | Palliative (P) | null | 2014-07-12 | DA | N | null | 290022441 | SUNITINIB |
| 290007170 | 290005497 | 1.79 | null | Palliative (P) | 2016-08-02 | 2016-08-02 | Capecitabine + Carboplatin + RT | 02 | N | 290022449 | CARBOPLATIN + PACLITAXEL |
| 290007171 | 290005497 | 1.78 | 95.6 | Palliative (P) | 2002-06-23 | 2015-04-24 | Cetuximab + CISPLATIN + FLUOROURACIL | 02 | N | 290022449 | CARBO + FLUOROURACIL |
| 290007173 | 290005499 | null | 97.1 | Adjuvant (A) | 2015-09-26 | 2015-10-06 | CAPECITABINE + CARBOPLATIN | Y | N | 290022458 | CAPECITABINE |
| 290007174 | 290007327 | 0 | 71 | Palliative (P) | 2017-09-20 | 2017-10-04 | Capecitabine | 02 | N | 290022470 | INTERAACT TRIAL |
| 290007175 | 290007327 | 1.61 | 65 | Adjuvant (A) | 2017-08-12 | 2017-09-08 | EVEROLIMUS | N | null | 290022470 | OXALIPLATIN + RALTITREXED |
| 290007176 | 290007328 | 1.73 | 98.5 | Adjuvant (A) | 2013-12-28 | 2014-02-01 | CISPLATIN + FLUOROURACIL + RT | N | N | 290022484 | CAPECITABINE + OXALIPLATIN |
| 290007177 | 290005501 | 1.6 | 67 | Neo-adjuvant (N) | 2016-10-15 | 2018-01-02 | EVEROLIMUS | 02 | N | 290022486 | CAPECITABINE + RT |
| 290007178 | 290005502 | 1.78 | 77.6 | Palliative (P) | 2016-06-30 | 2016-07-01 | Capecitabine | N | N | 290022492 | DOCETAXEL |
| 290007179 | 290005502 | 1.58 | 88.9 | Disease modification (D) | 2016-01-16 | 2016-06-14 | Cisplatin + Radiotherapy | null | N | 290022492 | CAPECITABINE + IRINOTECAN |
| 290007180 | 290005503 | 1.66 | 63.2 | Palliative (P) | 2014-07-08 | 2014-07-11 | LANREOTIDE | N | N | 290022501 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290007181 | 290005508 | 1.79 | 51.6 | Palliative (P) | 2018-06-15 | 2018-06-28 | Cisplatin + Etoposide po&iv 3 day | 2 | null | 290022503 | LANREOTIDE |
| 290007182 | 290005510 | 1.6 | 108 | Palliative (P) | 2015-02-26 | 2015-03-03 | Cisplatin 7 day | 02 | N | 290022508 | SUNITINIB |
| 290007183 | 290005510 | 1.88 | 100 | Palliative (P) | 2014-11-16 | 2014-12-11 | NIVOLUMAB | N | Y | 290022508 | CARBOPLATIN + CETUXIMAB + FU |
| 290007184 | 290005510 | 1.78 | null | Curative (C) | 2017-08-17 | 2017-09-07 | Cisplatin 100 + RT(H&N) 1 day | N | null | 290022508 | CARBOPLATIN |
| 290007185 | 290007334 | 1.9 | 61.6 | Disease modification (D) | 2013-10-13 | 2013-11-21 | Sunitinib | N | N | 290022520 | RITUXIMAB |
| 290007186 | 290005513 | 1.6 | 83 | Palliative (P) | null | 2017-08-30 | LENALIDOMIDE | N | N | 290022524 | CAPECITABINE + MITOMYCIN |
| 290007187 | 290005513 | null | 79.1 | Palliative (P) | 2014-07-19 | 2014-07-20 | Cisplatin + Radiotherapy | N | N | 290022524 | EVEROLIMUS |
| 290007188 | 290005514 | 1.75 | 71.5 | Palliative (P) | 2013-08-29 | 2013-09-18 | MCX | 02 | N | 290022526 | TEMOZOLOMIDE |